GlassScriptPhysician profile
Luis H Mariscal
NPI 1821231614
$3,045.16
in general payments reported to CMS, 2019-2025
45 companies · $263 in 2025
The $263 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $426 · 2020: $463 · 2021: $526 · 2022: $303 · 2023: $227 · 2024: $838 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,327.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Koya Medical, INC. | $476.06 | 2024 | Dayspring, Koya Medical |
| Amgen INC. | $186.62 | 2019-2022 | |
| Daiichi Sankyo INC. | $186.57 | 2019-2024 | Injectafer, Vanflyta |
| Novocure INC. | $179.20 | 2019-2025 | Optune, Optune Gio, Optune Lua (Novottf-200t) |
| Boston Scientific Corporation | $168.23 | 2019-2021 | |
| Eisai INC. | $150.29 | 2020-2023 | |
| Siemens Medical Solutions USA, INC. | $146.00 | 2024-2025 | Aria Radiation Therapy Management Software, Varian Ethos Treatment Planning, Truebeam |
| Janssen Biotech, INC. | $130.79 | 2019-2023 | |
| Dendreon Pharmaceuticals LLC | $126.81 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $104.15 | 2020-2024 | Tagrisso, Enhertu |
| E.R. Squibb & Sons, L.L.C. | $101.63 | 2019-2023 | Opdivo |
| Novartis Pharmaceuticals Corporation | $94.63 | 2019-2025 | |
| Myovant Sciences INC. | $75.07 | 2021-2022 | |
| Medtronic, INC. | $62.51 | 2023-2024 | Osteocool Rf Ablation System |
| Bayer Healthcare Pharmaceuticals INC. | $61.72 | 2019-2021 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Mariscal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.